Healthcare provider profile · identity verified

Steven J Heyden, MD

Family Practice · WHITEFISH BAY, WI · NPI 1184655680

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	520	139
Amlodipine Besylate	Amlodipine Besylate	295	82
Losartan Potassium	Losartan Potassium	265	78
Metformin Hcl	Metformin Hcl	176	48
Levothyroxine Sodium	Levothyroxine Sodium	166	48
Lisinopril	Lisinopril	159	42
Hydrochlorothiazide	Hydrochlorothiazide	122	39
Pantoprazole Sodium	Pantoprazole Sodium	121	36
Omeprazole	Omeprazole	117	38
Eliquis	Apixaban	116	23
Tamsulosin Hcl	Tamsulosin Hcl	113	25
Metoprolol Succinate	Metoprolol Succinate	110	33
Simvastatin	Simvastatin	110	34
Gabapentin	Gabapentin	109	27
Metoprolol Tartrate	Metoprolol Tartrate	98	25
Furosemide	Furosemide	91	27
Rosuvastatin Calcium	Rosuvastatin Calcium	87	27
Allopurinol	Allopurinol	86	23
Pravastatin Sodium	Pravastatin Sodium	81	20
Famotidine	Famotidine	80	17
Sertraline Hcl	Sertraline Hcl	77	16
Finasteride	Finasteride	74	18
Trazodone Hcl	Trazodone Hcl	73	14
Escitalopram Oxalate	Escitalopram Oxalate	69	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	69	19
Metformin Hcl Er	Metformin Hcl	68	19
Potassium Chloride	Potassium Chloride	66	21
Fluticasone Propionate	Fluticasone Propionate	64	26
Carvedilol	Carvedilol	60	19
Albuterol Sulfate Hfa	Albuterol Sulfate	58	25
Duloxetine Hcl	Duloxetine Hcl	55	18
Tramadol Hcl	Tramadol Hcl	55	14
Citalopram Hbr	Citalopram Hydrobromide	54	suppressed
Alprazolam	Alprazolam	52	13
Prednisone	Prednisone	51	39
Januvia	Sitagliptin Phosphate	49	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	13
Clopidogrel	Clopidogrel Bisulfate	46	11
Glimepiride	Glimepiride	46	15
Montelukast Sodium	Montelukast Sodium	46	11
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Clonazepam	Clonazepam	42	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	42	11
Atenolol	Atenolol	38	suppressed
Benazepril Hcl	Benazepril Hcl	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	13
Ozempic	Semaglutide	35	suppressed
Azithromycin	Azithromycin	34	28
Jardiance	Empagliflozin	34	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Fenofibrate	Fenofibrate	33	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Glipizide	Glipizide	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	15
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Terazosin Hcl	Terazosin Hcl	29	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Meloxicam	Meloxicam	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Temazepam	Temazepam	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	11
Enalapril Maleate	Enalapril Maleate	21	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Spironolactone	Spironolactone	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Lovastatin	Lovastatin	16	suppressed
Pregabalin	Pregabalin	15	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Carvedilol Er	Carvedilol Phosphate	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	11
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error